Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies.
about
Microtubule-targeting drugs induce Bcl-2 phosphorylation and association with Pin1Microtubule-targeting drugs induce bcl-2 phosphorylation and association with Pin1Apoptotic pathways as a therapeutic target for colorectal cancer treatmentThe Modulation of Apoptotic Pathways by GammaherpesvirusesDetailed Functional and Proteomic Characterization of Fludarabine Resistance in Mantle Cell Lymphoma CellsNimbolide targets BCL2 and induces apoptosis in preclinical models of Waldenströms macroglobulinemia.Identification of Ebp1 as a component of cytoplasmic bcl-2 mRNP (messenger ribonucleoprotein particle) complexes.Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres.Transferrin receptor targeted lipopolyplexes for delivery of antisense oligonucleotide g3139 in a murine k562 xenograft model.Isorhynchophylline, a Potent Plant Alkaloid, Induces Apoptotic and Anti-Metastatic Effects in Human Hepatocellular Carcinoma Cells through the Modulation of Diverse Cell Signaling Cascades.Single Nucleotide Polymorphisms in Selected Apoptotic Genes and BPDE-Induced Apoptotic Capacity in Apparently Normal Primary Lymphocytes: A Genotype-Phenotype Correlation AnalysisDiffuse large B cell lymphoma: using pathologic and molecular biomarkers to define subgroups for novel therapy.Advances in treating chronic lymphocytic leukemiaTargeted knockdown of Bcl2 in tumor cells using a synthetic TRAIL 3'-UTR microRNAThe anti-tumor activator sMEK1 and paclitaxel additively decrease expression of HIF-1α and VEGF via mTORC1-S6K/4E-BP-dependent signaling pathways4-vinylcyclohexene diepoxide: a model chemical for ovotoxicity.Fusion tyrosine kinases induce drug resistance by stimulation of homology-dependent recombination repair, prolongation of G(2)/M phase, and protection from apoptosis.How apoptosis is regulated, and what goes wrong in cancerMicroRNAs, cancer and cancer stem cellsEffects of bufalin on the proliferation of human lung cancer cells and its molecular mechanisms of action.Telmisartan induces apoptosis and regulates Bcl-2 in human renal cancer cells.Inhibition of lung tumor growth by targeting EGFR/VEGFR-Akt/NF-κB pathways with novel theanine derivativesSuppression of proliferation and migration in highly-metastatic lung cancer cells as well as tumor growth by a new synthesized compound TBrC and its molecular mechanisms of actionActivation of the mTOR signaling pathway in breast cancer MCF‑7 cells by a peptide derived from Porphyra yezoensis.Caspase-2 short isoform interacts with membrane-associated cytoskeleton proteins to inhibit apoptosis.Silencing of Pokemon enhances caspase-dependent apoptosis via fas- and mitochondria-mediated pathways in hepatocellular carcinoma cells.Garlic constituent diallyl trisulfide suppresses x-linked inhibitor of apoptosis protein in prostate cancer cells in culture and in vivo.Overexpression of DHX32 contributes to the growth and metastasis of colorectal cancer.Apoptosis in cancer: from pathogenesis to treatment.Regulation of nuclear factor-kappaB in intestinal epithelial cells in a cell model of inflammationMitochondrial dysfunction in cancer.Apoptotic Mechanisms of Peroxisome Proliferator-Activated Receptor-γ Activation in Acinar Cells During Acute Pancreatitis.MART-10, a New Generation of Vitamin D Analog, Is More Potent than 1α,25-Dihydroxyvitamin D(3) in Inhibiting Cell Proliferation and Inducing Apoptosis in ER+ MCF-7 Breast Cancer Cells.Cell survival and apoptosis signaling as therapeutic target for cancer: marine bioactive compounds.miR-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2Enhanced suppression of proliferation and migration in highly-metastatic lung cancer cells by combination of valproic acid and coumarin-3-carboxylic acid and its molecular mechanisms of action.A BCL2 promoter polymorphism rs2279115 is not associated with BCL2 protein expression or patient survival in breast cancer patients.Anti-tumor activity of N-thiolated beta-lactam antibiotics.Bim upregulation by histone deacetylase inhibitors mediates interactions with the Bcl-2 antagonist ABT-737: evidence for distinct roles for Bcl-2, Bcl-xL, and Mcl-1.Chemosensitization of prostate cancer by modulating Bcl-2 family proteins.
P2860
Q24551023-2FEF3978-8D7E-4474-B6E4-A135ECA129C9Q24551055-17BDB060-501A-4933-BB86-3B3ABFFF8F9EQ26738304-AE49501D-B007-4BA5-BDAF-03496A9B7456Q26747452-0E0E9115-3A2B-421A-AC38-7DD771DA1D83Q28547322-08B2BD75-284A-49D0-9ACE-B1F44F263AF2Q30848149-7DF4ED87-EA08-41DD-9ABB-33E69B77C47FQ33231031-072FF637-F7C4-4746-B186-96D7212329E2Q33370714-3FB6BC47-1B11-4AD1-A0B7-271ADDCAF6E1Q33418791-2794E2E7-0F79-41AD-988B-E9C5F0F3EB1DQ33755460-D7E7A8C9-71D7-4798-87AE-BA6E5EACB685Q33807908-E383E0DB-6BD6-4466-9015-5903CA88A039Q33846801-810D3E6C-E2CE-4F2C-9439-63F64576A083Q34019917-C09D4BD0-D348-4904-AA27-DF78BA4C1726Q34076762-62393160-AB93-4E0E-8199-6C35E413B9B6Q34227805-F685323E-1639-4311-A8D9-6AC14DC9AC1CQ34246525-0D4383E7-E952-4155-A9BE-8A57FBE93147Q34281241-6AEABE32-2717-464B-A439-5B265F0E8884Q34290061-4521AE30-2DCE-4BC7-8C9A-C8EA28D54B81Q34348967-ADA61DDE-D954-4E83-BCC5-CCD785160E16Q34368433-496B9C19-ABA4-4199-949E-68049D46B34BQ34433686-23930544-B811-43B2-8C97-1B8B97086487Q34483660-8E8EB48F-243E-4454-9311-7E64B2B4FE66Q34534784-3FBB54D7-2114-4A09-A43E-E820E734C1A0Q34626081-EF82D995-FC92-494C-B38F-B22CBCF3FEFDQ34808941-0D8EA82D-33FA-4D5B-957E-84050B45D355Q34852233-BDB08813-24DF-4FF7-A454-21EA5752FB36Q35024090-69541FD9-75ED-4D4A-B95D-0A63DF00CE05Q35188932-9B3CEB0A-0F51-4918-A7C7-531F1985E5B6Q35397889-96A4B45E-A7F9-4553-A007-AAF59E9B1B6CQ35609369-8C997912-863B-4EDA-BF6C-457032CB6FD6Q35903564-07F3C92B-D8DC-4FEB-B6AB-0F91EC9F7997Q36467284-85821D68-01B5-4841-BEC5-EE023276E0DDQ36488819-4A742467-AC34-4B96-9E66-684D2F0E51F3Q36655944-62F068C5-C001-4B32-BD09-EB86B9E73207Q36950630-5CF821C5-D18E-4D50-8AC8-0A583FC74283Q37039303-043ED95A-4353-468F-A046-C9E63C3B51C1Q37052173-8B78929B-CB34-460C-8CE4-EF4552747AD5Q37184379-D8736D2A-8A3B-4831-BD8B-CE3656CD5AC7Q37451892-ED162680-D0EB-4F93-BE5F-A9633F45A61AQ37713757-D2969B2C-900F-4F6D-B575-3676515EF28E
P2860
Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Bcl-2 family proteins: regulat ...... e in hematologic malignancies.
@en
type
label
Bcl-2 family proteins: regulat ...... e in hematologic malignancies.
@en
prefLabel
Bcl-2 family proteins: regulat ...... e in hematologic malignancies.
@en
P1476
Bcl-2 family proteins: regulat ...... ce in hematologic malignancies
@en
P2093
P433
P577
1997-10-01T00:00:00Z